Cargando…

Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events

IMPORTANCE: Tumor necrosis factor (TNF) inhibitors are common therapies for certain autoimmune diseases, such as rheumatoid arthritis. An association between TNF inhibitor exposure and inflammatory central nervous system (CNS) events has been postulated but is poorly understood. OBJECTIVE: To evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kunchok, Amy, Aksamit, Allen J., Davis, John M., Kantarci, Orhun H., Keegan, B. Mark, Pittock, Sean J., Weinshenker, Brian G., McKeon, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235930/ https://www.ncbi.nlm.nih.gov/pubmed/32421186 http://dx.doi.org/10.1001/jamaneurol.2020.1162

Ejemplares similares

Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions
por: Barakat, Benan, et al.
Publicado: (2022)

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders
por: Sechi, Elia, et al.
Publicado: (2021)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

Population-based study of “no evident disease activity” in MS
por: Parks, Natalie E., et al.
Publicado: (2018)

A multicenter comparison of MOG-IgG cell-based assays
por: Waters, Patrick J., et al.
Publicado: (2019)

Reproductive history and progressive multiple sclerosis risk in women
por: Zeydan, Burcu, et al.
Publicado: (2020)

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians
por: Majed, Masoud, et al.
Publicado: (2016)

Cervical spinal cord atrophy: An early marker of progressive MS onset
por: Zeydan, Burcu, et al.
Publicado: (2018)

CORL Expression in the Drosophila Central Nervous System Is Regulated by Stage Specific Interactions of Intertwined Activators and Repressors
por: Tran, Nancy L., et al.
Publicado: (2018)

Aquaporin-4 Immuneglobulin G Testing in 36 Consecutive Jamaican Patients with Inflammatory Central Nervous System Demyelinating Disease
por: Sandy, Sherri, et al.
Publicado: (2014)

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies
por: Liimatainen, Suvi, et al.
Publicado: (2018)

Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults
por: Dubey, Divyanshu, et al.
Publicado: (2022)

Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG
por: Jitprapaikulsan, Jiraporn, et al.
Publicado: (2020)

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine‐rich glioma‐inactivated protein 1
por: Feyissa, Anteneh M., et al.
Publicado: (2018)

Comparative Transcriptomic Analysis Reveals Molecular Profiles of Central Nervous System in Maternal Diapause Induction of Locusta migratoria
por: Jarwar, Aftab Raza, et al.
Publicado: (2019)

Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors
por: Rajappa, Prajwal, et al.
Publicado: (2022)

A new dawn for genetic association studies in multiple sclerosis
por: Kantarci, Orhun H.
Publicado: (2016)

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association
por: Alfugham, Nora, et al.
Publicado: (2017)

Autoimmune Encephalitis Misdiagnosis in Adults
por: Flanagan, Eoin P., et al.
Publicado: (2022)

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

Extent of radiological response does not reflect survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021)

Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome
por: McCombe, Jennifer A., et al.
Publicado: (2023)

Central nervous system effects of tumor necrosis factor alpha blockade
por: Schett, Georg
Publicado: (2011)

Paraneoplastic cerebellar ataxia with central hypoventilation
por: Kunchok, Amy, et al.
Publicado: (2016)

A comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgG
por: Alfugham, Nora, et al.
Publicado: (2016)

Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments
por: Shah, Shailee, et al.
Publicado: (2021)

Necrosis-induced apoptosis promotes regeneration in Drosophila wing imaginal discs
por: Klemm, Jacob, et al.
Publicado: (2021)

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
por: Sechi, Elia, et al.
Publicado: (2021)

Comparison of Parallel High-Throughput RNA Sequencing Between Knockout of TDP-43 and Its Overexpression Reveals Primarily Nonreciprocal and Nonoverlapping Gene Expression Changes in the Central Nervous System of Drosophila
por: Hazelett, Dennis J., et al.
Publicado: (2012)

NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006)

Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system
por: Ricci, Serena, et al.
Publicado: (2016)

Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
por: Chey, Shin Yee, et al.
Publicado: (2022)

High opioid doses, naloxone, and central nervous system active medications received by Medicare‐enrolled adults
por: Silva Almodóvar, Armando, et al.
Publicado: (2022)

Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders
por: Redenbaugh, Vyanka, et al.
Publicado: (2021)

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity
por: Vorasoot, Nisa, et al.
Publicado: (2023)

Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults
por: Ji, Jianling, et al.
Publicado: (2021)

DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment
por: Bernhardt, Denise, et al.
Publicado: (2022)

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
por: Höftberger, Romana, et al.
Publicado: (2020)

Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting
por: Körner, Heinrich, et al.
Publicado: (1997)

Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma
por: Foreman, Bronwen E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6clj19rq1d5f7jj5p2s29pd8en